Background: Enhanced recovery after surgery (ERAS) protocols are widely used worldwide. Recently, studies of the ERAS program in spinal surgery subspecialties have been reported. The aim of this study was to evaluate the impacts of ERAS in minimally invasive microdiscectomy (MD) surgery. Methods: This was a retrospective cohort study of patients undergoing MD at a single center. From March 2018 to March 2021, 286 patients were in the ERAS group. A total of 140 patients from March 2017 to February 2018 were in the conventional group. The outcomes included length of stay (LOS), the postoperative numeric rating scale (NRS), complications, 30-day readmission rate, 30-day reoperation rate and cost. Moreover, perioperative factors were also evaluated. Results: Compared with the conventional group, the LOS and cost were reduced in the ERAS group. There were no significant differences in the NRS, complication rate, 30-day readmission or reoperation rates between the groups. Furthermore, postoperative drainage volume, and postoperative opioid use were lower in the ERAS group. Conclusions: The ERAS protocol for MD surgery reduces LOS, cost and opioid use and accelerates patient recovery.
Intervertebral disc degeneration (IDD) is a leading cause of chronic low back pain, yet the molecular mechanisms driving its progression remain incompletely defined. Emerging evidence suggests that endoplasmic reticulum stress and the unfolded protein response (UPR) may play critical roles in disc cell dysfunction. Transcriptomic datasets (GSE70362 and GSE56081) from human nucleus pulposus tissues were integrated to identify UPR-related differentially expressed genes. Functional enrichment, gene set enrichment analysis, and gene set variation analysis analyses were performed to explore associated biological pathways. Protein–protein interaction networks, transcription factor–target predictions, and immune infiltration analyses were conducted. Two-sample Mendelian randomization was applied to assess potential causal relationships between UPR-related genes and IDD. Key genes were further validated using independent datasets and single-cell RNA sequencing data. A total of 26 UPR-related differentially expressed genes were identified, and protein–protein interaction network analysis with hub gene screening highlighted IRF1 , PRKD1 , CCND1 , and PDLIM1 as central regulators. Two-sample Mendelian randomization confirmed the causal associations of IRF1 and PRKD1 with IDD risk. Immune infiltration analysis revealed significant correlations between UPR-related genes and the activity of macrophages and T cells. Single-cell RNA sequencing further validated the differential expression and cell-type specificity of IRF1 and PRKD1 in degenerated nucleus pulposus tissues. This integrative multi-omics and Mendelian randomization study identifies IRF1 and PRKD1 as UPR-related drivers of IDD. These findings provide potential biomarkers and therapeutic targets for IDD management.